Test Price
550 AED✅ Home Collection Available
WT-1 Immunohistochemistry (IHC) Test in UAE | 550 AED | 2026 DHA Guidelines
تحليل WT-1 بالكيمياء النسيجية المناعية في الإمارات | 550 درهم | معتمد من هيئة الصحة بدبي
Executive Summary – UAE Clinical Excellence
Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing.
Premium Logistics: Paid Hospital-Grade Home Collection via ISO Certified Cold‑Chain Home Collection & VIP Mobile Phlebotomy.
Clinical Guidance: Telephonic Post‑Test Clinical Guidance in result interpretation.
Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
ملخص تنفيذي: ضمان دقة التشخيص بنسبة 99.9% من خلال معالجة معتمدة وفقًا لمعايير ISO. خدمة سحب منزلي فاخرة بتقنية سلسلة التبريد المعتمدة. استشارة طبية عبر الهاتف لتفسير النتائج. التحقق المباشر من التأمين عبر واتساب.
Overview
The WT-1 Immunohistochemistry (IHC) Test is a targeted diagnostic assay that detects Wilms Tumor 1 protein expression in formalin‑fixed, paraffin‑embedded (FFPE) tissue, aiding in the differential diagnosis of Wilms tumor, mesothelioma, and ovarian malignancies. In the UAE, this test is performed under strict DHA/MOHAP protocols, utilising a validated monoclonal antibody (clone 6F‑H2) on automated staining platforms for enhanced reproducibility.
| Feature | DHA‑Certified WT‑1 IHC Test | Standard IHC Panel (Generic) |
|---|---|---|
| Methodology | Validated IHC using WT‑1 (6F‑H2) monoclonal antibody, ISO 9001:2015 | Polyclonal or unvalidated WT‑1 antibody; variable standardisation |
| Turnaround Time | FFPE block: 5 days; Large/complex tissue: 7 days | Often 10–14 days without guaranteed quality metrics |
| Diagnostic Specificity | 99.9% with built‑in tissue controls and blinded second read | Variable, often lacking external quality assessment |
| Price (AED) | 550 | 300 – 450 (often with add‑on charges) |
| Compliance | Federal Decree‑Law No. 41 of 2024, UAE PDPL, CDS Law 2026 (Minor consent) | May lack explicit UAE healthcare law adherence |
Physician Insight & Safety Protocol
“As a DHA‑licensed oncologist, I interpret every WT‑1 IHC result within the complete clinical picture—no single stain replaces a multidisciplinary review. This test is a powerful adjunct when paired with histomorphology and radiological findings, but it must never be the sole basis for a cancer diagnosis. My team and I are committed to guiding you through the implications of your result with empathy and scientific rigor.”
— Dr. PRABHAKAR REDDY, DHA License No. 61713011
⚠️ Medication Warning
Do not discontinue any prescribed medication without consulting your doctor. This test does not replace therapeutic decisions, and abrupt stoppage of anti‑cancer or supportive therapy can be harmful.
Patient Safety – Exclusion Criteria & Emergency Red Flags
- Exclusion: Inability to provide a formalin‑fixed, paraffin‑embedded tissue block; active bleeding diathesis precluding biopsy; known allergy to local anaesthetics used during tissue sampling.
- Red Flags (seek emergency care): Uncontrolled bleeding after biopsy, severe pain unresponsive to analgesia, or signs of infection (fever, warmth, pus) at the biopsy site. For any such event, immediately go to the nearest emergency department.
Patient FAQ & Clinical Guidance
1. What does the WT‑1 IHC test detect?
English: The WT‑1 IHC test detects Wilms tumor protein expression in tissue to aid diagnosis of Wilms tumor, mesothelioma, and ovarian malignancies. This immunohistochemical stain highlights the WT‑1 antigen within the cell nuclei, allowing pathologists to differentiate between tumour types that may appear similar under routine microscopy. A positive result suggests the presence of a WT‑1‑expressing neoplasm, but final correlation with clinical history and imaging is essential.
يكتشف اختبار WT‑1 بالكيمياء النسيجية المناعية بروتين ورم ويلمز في الأنسجة للمساعدة في تشخيص ورم ويلمز، ورم المتوسطة، والأورام الخبيثة في المبيض.
2. How should I prepare for the?
English: Provide a formalin‑fixed paraffin‑embedded tissue block and histopathology report for accurate WT‑1 immunohistochemical analysis. Your surgical team or pathology lab will prepare the specimen according to strict DHA guidelines. No fasting or medication adjustment is required before sample collection, but you must submit a copy of the original biopsy report and clinical notes to ensure optimal interpretation.
قدّم كتلة نسيجية مثبتة بالفورمالين ومضمنة بالبارافين مع تقرير التشريح المرضي لتحليل دقيق لـ WT‑1 بالكيمياء النسيجية المناعية.
3. What do positive WT‑1 results mean?
English: A positive WT‑1 IHC result indicates protein overexpression, commonly linked to Wilms tumor but requiring clinical correlation. This finding must be integrated with tumour morphology, patient age, and additional markers; false positives can occur in other malignancies or benign conditions. Your oncologist will interpret the result within your full diagnostic profile and may recommend further molecular testing.
تشير نتيجة WT‑1 الإيجابية إلى زيادة إفراز البروتين، وغالبًا ما ترتبط بورم ويلمز ولكنها تتطلب ربطًا سريريًا.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians